x

75% of people globally want unbiased news (Pew Research) but are concerned they're not getting that.

Get balanced coverage with Symby. See how stories are covered across diverse outlets and spot when one side covers a story the other skips.

PODCAST

DermConsult

There’s a lot dermatology specialists need to consider when ensuring patients have healthy skin. And at a time when clinical research is increasingly defining skin conditions—and the practice of dermatology itself—as “more than skin deep,” turn to DermConsult. In this special series, dermatology specialists share their expert advice on the diagnosis and treatment of a variety of skin conditions. They also explore the latest clinical research and their very own case studies, so you can rest assured

science & medicine medicine

All Episodes

00:00:00

Beyond the Surface: The Impact of Psoriasis on...

DermConsult ·

2024/06/13

Guest: John Barbieri, MD, MBA, FAAD Patients with psoriasis die about five years younger than those without the condition, and cardiovascular disease is the leading cause of this premature mortality. Tune in to hear Dr. John Barbieri discuss strategies to identify risk factors and improve cardiovascular disease prevention in patients with psoriasis. Dr. Barbieri is an Assistant Professor of Dermatology at Brigham and Women's Hospital at Harvard Medical School in Boston.

en

00:00:00

Patients with Psoriasis: Addressing Advocacy and...

DermConsult ·

2024/06/11

Host: Raj Chovatiya, MD, PhD Guest: Jason E. Hawkes, MD, MS, FAAD There are a few key points that dermatologists need to keep at the forefront of conversations to help bridge education gaps around psoriasis. One is to try and eliminate burdens that are deterring practitioners in dermatology from using highly effective and very safe medications. To learn more on how we can have a positive impact on education gaps and advocacy, join Dr. Raj Chovatiya as he speaks with Dr. Jason

en

00:00:00

Newly Diagnosed Psoriasis Patients: Uncovering Racial...

DermConsult ·

2024/06/10

Guest: Shari Lipner, MD A recent study was conducted looking at initial therapies for newly diagnosed psoriasis patients by race. Prior studies have shown differences by race in terms of emerging treatments for different dermatological diseases, which have also shown differential biologic treatments based on race. To learn about the findings and how we can help fill this gap, join Dr. Shari Lipner, Associate Professor of Clinical Dermatology at Weill Cornell Medicine and co-author of

en

00:00:00

Understanding the Impact of Depressive Symptoms in...

DermConsult ·

2023/12/19

Host: Charles Turck, PharmD, BCPS, BCCCPGuest: Neda Shahriari, MD This study assessed the link between depressive symptoms in real-world patients with psoriasis to help identify characteristics for those at risk. What were the findings? To learn more, join Dr. Charles Turck as he speaks with Dr. Neda Shahriari, Board-Certified Dermatologist at Brigham and Women’s Hospital in Boston, Massachusetts.

en

00:00:00

Strategies for the Long-Term Control of Atopic...

DermConsult ·

2023/12/04

Host: Raj Chovatiya, MD, PhD Guest: Melinda Gooderham, MSc, MD, FRCPC Due to the evolving treatment landscape, the way we think about treating adult and elderly patients with atopic dermatitis has shifted. So what are some special considerations we need to think about when selecting a treatment option for long-term control, and how can we best involve patients in the decision-making process? Joining Dr. Raj Chovatiya to help answer these and other key questions in atopic dermatitis

en

00:00:00

Poster Pearl: Itch Control Matters Most to Patients...

DermConsult ·

2023/12/04

Host: Raj Chovatiya, MD, PhD Guest: Steven R. Feldman, MD, PhD To gain a better understanding of the different treatment attributes that patients with moderate-to-severe atopic dermatitis value most, a discrete choice experiment was conducted. And now, the results are in, with itch control being the top attribute. Joining Dr. Raj Chovatiya to share this and other key findings from his research that was featured as a poster at the 2023 Fall Clinical Dermatology conference is Dr

en

00:00:00

Biosimilars in Psoriasis: The Future of Treatment

DermConsult ·

2023/09/12

Host: Raj Chovatiya, MD, PhD Guest: Steven R. Feldman, MD, PhD The biologics we know are revolutionary treatments for our patients with psoriasis and now other inflammatory skin diseases. So how do biosimilars play a part in the evolving treatment of psoriasis? Learn more with Dr. Raj Chovatiya as he dives further into biosimilars with Dr. Steve Feldman, Professor of Dermatology, Pathology, Social Sciences, and Health Policy at the Wake Forest University School of Medicine in

en

00:00:00

Psoriasis Treatment Redefined: Exploring the Impact...

DermConsult ·

2023/09/01

Host: Raj Chovatiya, MD, PhD Guest: George Han, MD, PhD The discovery of the IL-23 pathway has revolutionized the treatment of psoriasis. Learn more about the current state of IL-23 inhibition in psoriasis management with Dr. Raj Chovatiya and Dr. George Han, Associate Professor in the Department of Dermatology at the Donald and Barbara Zucker School of Medicine at Hofstra/Northwell in Uniondale, New York.

en

00:00:00

Applying Shared Decision-Making to Atopic Dermatitis...

DermConsult ·

2023/09/01

Host: Raj Chovatiya, MD, PhD Guest: Matthew Zirwas, MD Guest: Douglas DiRuggiero, DMSc, PA-C When managing atopic dermatitis, it’s up to the patient to determine how much therapeutic intervention they want to pursue, which underscores the importance of applying shared decision-making to practice. Joining Dr. Raj Chovatiya to share their perspectives on how we can utilize shared decision-making in atopic dermatitis care are Dr. Matthew Zirwas and Mr. Douglas DiRuggiero. Dr

en

00:00:00

Treating Atopic Dermatitis: A Look at the Current &...

DermConsult ·

2023/09/01

Host: Raj Chovatiya, MD, PhD Guest: Jennifer Soung, MD Guest: Einjuan James Song, MD, FAAD The atopic dermatitis treatment landscape has evolved over the past several years. To catch up on the current treatment options available and the novel therapies in development, Dr. Raj Chovatiya speaks with Drs. James Song and Jennifer Soung. Dr. Song is the Director of Clinical Research for Frontier Dermatology Partners in Everett, Washington, and Dr. Soung is the Director of Clinical

en

00:00:00

From Pathophysiology to Therapeutic Progress: TYK2's...

DermConsult ·

2023/08/31

Host: Raj Chovatiya, MD, PhD Guest: George Han, MD, PhD Our understanding of TYK2’s role in the pathophysiology of psoriasis has recently evolved, leading to new treatment options like deucravacitinib. Deucravacitinib is the first approved TYK2 inhibitor approved for moderate to severe plaque psoriasis. Learn more about this treatment option and the role of TYK2 with Dr. Raj Chovatiya and Dr. George Han, Associate Professor in the Department of Dermatology at the Donald and Barbara

en

00:00:00

Breakthroughs in Generalized Pustular Psoriasis...

DermConsult ·

2023/08/25

Host: Raj Chovatiya, MD, PhD Guest: Jason E. Hawkes, MD, MS, FAAD Generalized pustular psoriasis is a rare inflammatory skin disease that can be life-threatening if left untreated, and treatment typically involves the use of therapies approved for plaque psoriasis. However, that could all be changing thanks to the recent understanding of IL-36’s role in generalized pustular psoriasis and the development of the treatment option spesolimab. Learn more with Dr. Raj Chovatiya and Dr

en

00:00:00

A New Era in Plaque Psoriasis Care: Examining Topical...

DermConsult ·

2023/08/23

Host: Raj Chovatiya, MD, PhD Guest: Jason E. Hawkes, MD, MS, FAAD Roflumilast and tapinarof are two of the new topical nonsteroidal therapies for plaque psoriasis that have several advantages over the traditional topical steroids. Learn more about how emerging topical nonsteroidals could impact your patients with plaque psoriasis with Dr. Raj Chovatiya and Dr. Jason Hawkes, a medical dermatologist in the Greater Sacramento area who also sits on the National Psoriasis Foundation

en

00:00:00

Preventing Disease Recurrence with Adjuvant Therapy...

DermConsult ·

2023/06/09

Host: Jason J. Luke, MD, FACP Guest: Tara C. Mitchell, MD The 5-year recurrence rates for stage IIB and IIC melanoma are up to 46%, but now new immunotherapy options are FDA-approved for the adjuvant treatment of stage IIB and IIC melanoma. Find out why this matters and hear Drs. Jason Luke and Tara Mitchell break down the latest data on treating stage IIB and IIC melanoma with adjuvant immunotherapy.

en

00:00:00

Reviewing New Therapies for Hidradenitis Suppurative

DermConsult ·

2023/05/22

Host: Raj Chovatiya, MD, PhD Guest: Martina J. Porter, MD Two of the biggest trials were recently completed for the use of IL-17 inhibitors for treating hidradenitis suppurative (HS). So what data should we know about? In this episode, Dr. Raj Chovatiya is joined by Dr. Martina Porter, Dermatologist at Beth Israel Deaconess Medical Center and Assistant Professor of Dermatology at Harvard Medical School.

en

00:00:00

Investigating Hidradenitis Suppurativa: A...

DermConsult ·

2023/05/11

Host: Raj Chovatiya, MD, PhD Guest: Martina J. Porter, MD For patients with hidradenitis suppurativa (HS), the exact cause of the condition is still being researched. So what therapies are currently available to treat this painful condition? To discuss what you need to know, Dr. Raj Chovatiya is joined by Dr. Martina Porter, Dermatologist at Beth Israel Deaconess Medical Center and Assistant Professor of Dermatology at Harvard Medical School.

en

00:00:00

Exploring Emerging Therapies for Alopecia Areata

DermConsult ·

2023/04/04

Host: Raj Chovatiya, MD, PhD Guest: Britt Craiglow, MD The future looks promising for alopecia areata patients as two JAK inhibitors have been tested in clinical trials while other treatment studies are ongoing. So what should clinicians know about these therapies? Learn more as Dr. Raj Chovatiya speaks to Dr. Britt Craiglow, Adjunct Associate Professor at the Yale School of Medicine and Double Board-Certified Dermatologist with Dermatology Physicians of Connecticut.

en

00:00:00

Alopecia Areata: Exploring New Data

DermConsult ·

2023/03/29

Host: Raj Chovatiya, MD, PhD Guest: Britt Craiglow, MD Initially approved for the treatment of rheumatoid arthritis, baricitinib is now the first FDA-approved treatment for patients with alopecia areata. So what can patients look forward to with this new therapy? Dive in with Dr. Raj Chovatiya as he’s joined by Dr. Britt Craiglow, Adjunct Associate Professor at the Yale School of Medicine and Double Board-Certified Dermatologist at Dermatology Physicians of Connecticut.

en

00:00:00

Overcoming Obstacles to Medication Access in Dermatology

DermConsult ·

2023/02/15

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Justin Cheeley, MD Proper access to medication can present challenges for the doctor and patient but is necessary to achieve optimal patient outcomes. So how can they work together to eliminate this burden? To discuss this further, Dr. Mary Katherine Cheeley is joined by Dr. Justin Cheeley, Assistant Professor in the Departments of General Internal Medicine and Dermatology and the Director of Inpatient Dermatology at

en

00:00:00

Diagnosing & Treating Pyoderma Gangrenosum

DermConsult ·

2023/02/14

Host: Mary Katherine Cheeley, PharmD, BCPS, CLS, FNLA Guest: Justin Cheeley, MD Patients with IBD, arthritis, or other disorders of the immune system may be at a higher risk for developing pyoderma gangrenosum (PG). So how can clinicians better manage their patients with PG? Explore this rare condition as Dr. Mary Katherine Cheeley is joined by Dr. Justin Cheeley, Assistant Professor in the Departments of General Internal Medicine and Dermatology and the Director of Inpatient

en

64 results

Similar Podcasts

科学史评话最新专辑

科学史评话

Hablando con Científicos - Cienciaes.com

cienciaes.com

天方烨谈

基因频道

The Permaculture Podcast

Scott Mann

汪诘：科学有故事（主打）

科学有故事